Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Metabolic syndrome and ALT: a community study in adult Koreans

Abstract

OBJECTIVE: To investigate an association between the metabolic syndrome (MS) and alanine aminotransferase (ALT) of normal ranges.

DESIGN: A population-based cross-sectional survey in three rural communities, South Korea.

SUBJECTS: A total of 1248 men and 2157 women aged 30 y and older.

MEASUREMENTS: Body mass index (BMI), waist circumference, fasting blood lipid and glucose, resting blood pressure, and ALT.

RESULTS: ALT and BMI increased with an addition of the MS components. A consistent association between ALT more than 15 IU/l and the MS was found in both sexes, independently of age, education, BMI, smoking, alcohol drinking, and sedentary life style. The odds ratios for the MS in the highest quintiles of ALT were 7.1-fold higher than the reference quintile in men and 2.1-fold higher in women. The likelihood ratio tests for trend were also significant with ALT increments (P<0.001 for trend).

CONCLUSION: The MS is significantly associated with the higher quintiles of normal ALT in both genders. ALT could be a sensitive marker of hepatic dysfunction associated with the MS, even in the range below the current limit.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ford ES . The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003; 168: 351–358.

    Article  CAS  PubMed  Google Scholar 

  2. Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner SM . Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42–47.

    Article  CAS  PubMed  Google Scholar 

  3. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W . Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000; 23: 1835–1839.

    Article  CAS  PubMed  Google Scholar 

  4. Kopp HP, Kopp CW, Festa A, Krzyzanowska K, Kriwanek S, Minar E, Roka R, Schernthaner G . Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003; 23: 1042–1047.

    Article  CAS  PubMed  Google Scholar 

  5. Straub RH, Hense HW, Andus T, Scholmerich J, Riegger GA, Schunkert H . Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab 2000; 85: 1340–1344.

    Article  CAS  PubMed  Google Scholar 

  6. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET . Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002; 105: 564–569.

    Article  PubMed  Google Scholar 

  7. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L . Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.

    Article  CAS  PubMed  Google Scholar 

  8. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V . Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation. Atherosclerosis 2002; 165: 285–292.

    Article  CAS  PubMed  Google Scholar 

  9. Ridker PM, Buring JE, Cook NR, Rifai N . C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391–397.

    Article  PubMed  Google Scholar 

  10. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N . Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844–1850.

    Article  CAS  PubMed  Google Scholar 

  11. James O, Day C . Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999; 353: 1634–1636.

    Article  CAS  PubMed  Google Scholar 

  12. Scheen AJ, Luyckx FH . Obesity and liver disease. Best Pract Res Clin Endocrinol Metab 2002; 16: 703–716.

    Article  CAS  PubMed  Google Scholar 

  13. Clark JM, Brancati FL, Diehl AM . The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960–967.

    Article  CAS  PubMed  Google Scholar 

  14. Dixon JB, Bhathal PS, O'Brien PE . Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91–100.

    Article  CAS  PubMed  Google Scholar 

  15. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ . Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286–1292.

    Article  PubMed  Google Scholar 

  16. Alderman MH . Measures and meaning of blood pressure. Lancet 2000; 355: 159.

    Article  CAS  PubMed  Google Scholar 

  17. Lee WG, Kwak YS, Lee DH, Hwang YS, Lee KN . Clinical pathology laboratory inspection and accreditation in Korea 1: development of the system and its trial. Korean J Clin Pathol 2001; 21: 86–92.

    Google Scholar 

  18. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486–2497.

  19. Steering Committee of the Western Pacific Region of the World Health Organization, the International Association for the Study of Obesity, and the International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Health Communications Australia Pty Ltd: Melbourne, Australia; 2000.

  20. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW . Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196–4200.

    CAS  PubMed  Google Scholar 

  21. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP . The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998; 128: 127–137.

    Article  CAS  PubMed  Google Scholar 

  22. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM . Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002; 22: 1668–1673.

    Article  CAS  PubMed  Google Scholar 

  23. Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L . Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999; 48: 94–98.

    Article  CAS  PubMed  Google Scholar 

  24. Nagore N, Scheuer PJ . The pathology of diabetic hepatitis. J Pathol 1988; 156: 155–160.

    Article  CAS  PubMed  Google Scholar 

  25. Angulo P, Keach JC, Batts KP, Lindor KD . Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356–1362.

    Article  CAS  PubMed  Google Scholar 

  26. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC . Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999; 18: 353–358.

    Article  CAS  PubMed  Google Scholar 

  27. Kopelman PG . Obesity as a medical problem. Nature 2000; 404: 635–643.

    Article  CAS  PubMed  Google Scholar 

  28. Caldwell SH, Hespenheide EE, Redick JA, Iezzoni JC, Battle EH, Sheppard BL . A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol 2001; 96: 519–525.

    Article  CAS  PubMed  Google Scholar 

  29. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N . Metformin in non-alcoholic steatohepatitis. Lancet 2001; 358: 893–894.

    Article  CAS  PubMed  Google Scholar 

  30. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, Torimura T, Inuzuka S, Sata M, Tanikawa K . Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27: 103–107.

    Article  CAS  PubMed  Google Scholar 

  31. Facchini FS, Hua NW, Stoohs RA . Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 931–939.

    Article  CAS  PubMed  Google Scholar 

  32. Patt CH, Yoo HY, Dibadj K, Flynn J, Thuluvath PJ . Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in an executive health-screening program. Dig Dis Sci 2003; 48: 797–801.

    Article  CAS  PubMed  Google Scholar 

  33. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G . Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1–10.

    Article  CAS  PubMed  Google Scholar 

  34. Mukai M, Ozasa K, Hayashi K, Kawai K . Various S-GOT/S-GPT ratios in nonviral liver disorders and related physical conditions and life-style. Dig Dis Sci 2002; 47: 549–555.

    Article  CAS  PubMed  Google Scholar 

  35. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR . Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002; 17: 457–462.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Shin HR, Kim JY, Ohno T, Cao K, Mizokami M, Risch H, Kim SR . Prevalence and risk factors of hepatitis C virus infection among Koreans in rural area of Korea. Hepatol Res 2000; 17: 185–196.

    Article  CAS  PubMed  Google Scholar 

  37. Friedman LS, Dienstag JL, Watkins E, Hinkle CA, Spiers JA, Rieder SV, Huggins CE . Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Intern Med 1987; 107: 137–144.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was funded by grants for National Health Promotion from the Ministry of Health & Welfare of Korea. We thank the residents of Gokseong, Goheung, and Namwon areas for their participation in the survey and the staff of the public health centers for their cooperation in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S-K Jeong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeong, SK., Nam, HS., Rhee, JA. et al. Metabolic syndrome and ALT: a community study in adult Koreans. Int J Obes 28, 1033–1038 (2004). https://doi.org/10.1038/sj.ijo.0802698

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802698

Keywords

This article is cited by

Search

Quick links